The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus

Inclusion Criteria: * Complete HMS5552 treatment and safety visit; * HbA1c \< 8.0% was detected in our laboratory; * Researchers judged the stability of glucose control based on the data of subjects'visits during HMS5552 treatment and the indicators of our hospital; * Subjects are able and willing to monitor peripheral blood sugar and regularity of diet and exercise; * Willing to sign written informed consent and abide by the research program. Exclusion Criteria: * There was a state of illness in the subjects who could not complete the follow-up during the observation period. * The researchers judged that subjects'compliance with HMS5552 was affected during treatment.